CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Clover Health Investments, Corp. /De quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2024.
  • Clover Health Investments, Corp. /De Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $401M, a 0.98% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $401M +$3.9M +0.98% Dec 31, 2024 10-K 2025-03-03
Q4 2023 $397M +$27.4M +7.41% Dec 31, 2023 10-K 2025-03-03
Q4 2022 $370M +$93.7M +34% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $276M +$113M +69% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $163M Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.